Search Results - "press release"

Suggested Topics within your search.
Refine Results
  1. 21
    Cover Image

    Bayer registered a new indication for rivaroxaban for use in patients with coronary heart disease or peripheral artery disease in the European Union and USA by Bayer Company Press Release

    Published 2018
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 22
    Cover Image

    PREVENTION OF SEVERE INFECTIONS IN PATIENTS WITH GENETIC DISORDERS OF THE COMPLEMENT SYSTEM REGULATION TREATING WITH ECULIZUMAB: PRESS RELEASE ON THE INTERDISCIPLINARY EXPERT COUNCIL MEETING by Editorial article

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  3. 23
    Cover Image

    POST-EVENT PRESS RELEASE OF THE XXIII CONVENTION OF PEDIATRICIANS OF RUSSIA "ACTUAL PROBLEMS OF PEDIATRICS" ON THE TOPIC "PREVENTIVE VACCINATION OF PURULENT BACTERIAL MENINGITIS" by article Editorial

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  4. 24
    Cover Image

    PREVENTION OF SEVERE INFECTIONS IN PATIENTS WITH GENETIC DISORDERS OF THE COMPLEMENT SYSTEM REGULATION TREATING WITH ECULIZUMAB: PRESS RELEASE ON THE INTERDISCIPLINARY EXPERT COUNCIL MEETING by Editorial article

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  5. 25
    Cover Image

    Implementation of the scientifically recommended vaccine priority list <em>- A Press Release from the College of Community Physicians of Sri Lanka</em> by Co -Editors

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:
  6. 26
    Cover Image

    New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) by Article Editorial

    Published 2016
    Connect to this object online.
    Book

    Save to List
    Saved in:
  7. 27
    Cover Image

    New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) by Article Editorial

    Published 2016
    Connect to this object online.
    Book

    Save to List
    Saved in:
  8. 28
    Cover Image

    NEW DATA OF EXTENSIVE RESEARCH PROGRAM AND THE RESULTS OF STUDIES IN REAL CLINICAL PRACTICE FROM DIFFERENT COUNTRIES REAFFIRMED THE HIGH EFFICACY AND A FAVORABLE SAFETY PROFILE OF RIVAROXABAN (XARELTO®) FROM THE BAYER COMPANY PRESS RELEASE OF THE BAYER COMPANY by article editorial

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  9. 29
    Cover Image

    NEW DATA OF EXTENSIVE RESEARCH PROGRAM AND THE RESULTS OF STUDIES IN REAL CLINICAL PRACTICE FROM DIFFERENT COUNTRIES REAFFIRMED THE HIGH EFFICACY AND A FAVORABLE SAFETY PROFILE OF RIVAROXABAN (XARELTO®) FROM THE BAYER COMPANY PRESS RELEASE OF THE BAYER COMPANY by article editorial

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  10. 30
    Cover Image

    Effective communications strategies to increase the impact of environmental health research by Rebecca E. Fuoco, Carol F. Kwiatkowski, Linda S. Birnbaum, Arlene Blum

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:
  11. 31
    Cover Image

    IХ NATIONAL CONGRESS ON INTERNAL MEDICINE

    Published 2015
    Connect to this object online.
    Book

    Save to List
    Saved in:
  12. 32
    Cover Image

    CONFERENCE "GENETIC TESTING AS A SOCIAL RESPONSIBILITY OF CITIZENS AND A DISABILITY PREVENTION"

    Published 2015
    Connect to this object online.
    Book

    Save to List
    Saved in:
  13. 33
    Cover Image

    IХ NATIONAL CONGRESS ON INTERNAL MEDICINE

    Published 2015
    Connect to this object online.
    Book

    Save to List
    Saved in:
  14. 34
    Cover Image

    RIVAROXABAN HAS DEMONSTRATED AN ADVANTAGE OVER ACETYLSALICYLIC ACID IN PREVENTING THE RECURRENCE OF VENOUS THROMBOEMBOLIC EVENTS IN THE EINSTEIN CHOICE STUDY by . Editorial

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  15. 35
    Cover Image

    CONFERENCE "GENETIC TESTING AS A SOCIAL RESPONSIBILITY OF CITIZENS AND A DISABILITY PREVENTION"

    Published 2015
    Connect to this object online.
    Book

    Save to List
    Saved in:
  16. 36
    Cover Image

    IХ NATIONAL CONGRESS ON INTERNAL MEDICINE

    Published 2015
    Connect to this object online.
    Book

    Save to List
    Saved in:
  17. 37
    Cover Image

    DATA OF THE RECENTLY PUBLISHED SWISS STUDY SWIVTER (THE SWISS VENOUS THROMBOEMBOLISM REGISTRY) DEMONSTRATE THE REPRODUCIBILITY OF THE RESULTS OF RANDOMIZED TRIALS IN REAL CLINICAL... by статья Редкционная

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  18. 38
    Cover Image

    RIVAROXABAN OF THE BAYER COMPANY SIGNIFICANTLY (BY 24%) REDUCES THE RISK OF STROKE, CARDIOVASCULAR DEATH AND MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE O... by статья Редакционная

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:
  19. 39
    Cover Image

    CONFERENCE "GENETIC TESTING AS A SOCIAL RESPONSIBILITY OF CITIZENS AND A DISABILITY PREVENTION"

    Published 2015
    Connect to this object online.
    Book

    Save to List
    Saved in:
  20. 40
    Cover Image

    RIVAROXABAN HAS DEMONSTRATED AN ADVANTAGE OVER ACETYLSALICYLIC ACID IN PREVENTING THE RECURRENCE OF VENOUS THROMBOEMBOLIC EVENTS IN THE EINSTEIN CHOICE STUDY by . Editorial

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: